Obesity-hypoventilation-syndrome: the role of nocturnal CPAP therapy

D. M. Toraldo, G. Nicolardi, F. De Nuccio (Lecce, Italy)

Source: Annual Congress 2004 - CPAP therapy for OSA
Session: CPAP therapy for OSA
Session type: Thematic Poster Session
Number: 3499
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. M. Toraldo, G. Nicolardi, F. De Nuccio (Lecce, Italy). Obesity-hypoventilation-syndrome: the role of nocturnal CPAP therapy. Eur Respir J 2004; 24: Suppl. 48, 3499

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CPAP non-compliance; the role of insomnia
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Is the daytime CPAP titration effective for determining therapeutic pressure levels in OSA patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 417s
Year: 2001

Does CPAP use reflect effective CPAP treatment?
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002

Initiation of nasal CPAP therapy without a preceding sleep study?
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Can CPAP therapy for paediatric OSA ever be stopped?
Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill
Year: 2019


Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment
Source: Eur Respir Monogr 2020; 88: 118-142
Year: 2020


Insulin resistance and patterns of continuous glucose monitoring in sleep apnoea patients: relationship with nocturnal hypoxemia and CPAP therapy
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Clinical implications of residual sleep apnoea after chronic CPAP therapy
Source: Breathe 2011; 7: 289-290
Year: 2011

Effects of sleep apnoea therapy on blood pressure and metabolism: a CPAP sex gap?
Source: Eur Respir J, 50 (2) 1700987; 10.1183/13993003.00987-2017
Year: 2017



Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Mild OSAS: Is CPAP therapy actually required for these patients?
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Automatic nCPAP therapy is not equivalent to autotitration in the treatment of OSAS
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Compliance of positive airway pressure therapy in patients with sleep related breathing disorder
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Treatment options for central sleep apnea (including auto-CPAP)
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005

Improved adherence with PAP therapy after switching from CPAP to bilevel for non-compliant OSA patients
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018